BNY has spent the past week quietly unwinding the defensive options posture that defined the stock all spring — a meaningful shift just three weeks out from Q2 earnings on July 15.
The change in options positioning is the most striking development since the previous note. The put/call ratio has dropped to 1.35, well below both the 20-day average of 1.63 and the 52-week high of 1.74 hit in late May. The z-score of -2.53 means the current reading is nearly two and a half standard deviations below the recent norm — a near-reversal of the persistent defensive skew that had held throughout April and May. That shift is notable precisely because BNY's baseline PCR has historically run high; a reading this far below average represents a genuine change in market character, not just normal oscillation. Institutional holders appear to have dialled back the put hedges that were a constant feature of positioning for most of Q2.
Short interest reinforces the cautious-but-not-crowded picture. At 1.57% of free float — down a further 2.6% on the week — the short book remains thin and continues to edge lower. The one-month jump of around 19% now looks like a base effect from the late-May step-down rather than a structural rebuild. Borrowing costs are minimal at 0.29% annually, and borrow availability is essentially limitless at current levels, with over 380 million shares available. There is no meaningful squeeze dynamic here and no sign that bearish conviction is hardening ahead of the print.
The Street case for BNY rests on a consistent track record of beating estimates — the EPS surprise factor scores in the 77th percentile — combined with structural revenue tailwinds in custody and markets. The bull argument centres on 13% year-on-year revenue growth in Markets and Wealth Services, a near-28% ROTCE, and an EPS growth trajectory pointing to double-digit gains through 2026. Bears flag rising expenses, balance sheet sensitivity to a high-rate environment, and geopolitical risks to capital markets activity. The mean analyst price target of $145.23 is marginally below the current price of $147.29, suggesting the Street is broadly in line with where the stock is trading — neither aggressively bullish nor pushing back. The PE has expanded roughly 2.4% over the past 30 days to 15.6x, a modest re-rating that tracks the 5.8% one-month price gain. BNY scores at the 96th percentile on dividend quality, though the dividend history data in this note is dated and should not be read as current yield guidance.
The most recent earnings prints offer useful context. In April, BNY moved 2.4% higher on the day of results and held nearly all of that gain five days later. The prior Q4 print produced a similar pattern — up 2.2% on the day, then extending to 6.8% over the following week. Neither reaction was dramatic, consistent with a stock where investors tend to be more focused on the quality of fee revenue and custody flows than on headline EPS.
Closest peer STT rose 3.8% on the week against BNY's 2.0%, while NTRS added 2.0% — both broadly in step with the custodian bank complex. GS and MS edged lower on the day, suggesting modest divergence between pure-play custody names and the broader investment bank peer group heading into the earnings window.
With the defensive options hedge now largely unwound, the July 15 print becomes a test of whether fee revenue and custody asset growth can justify the stock's current valuation near all-time highs — and whether the PCR, having reset sharply lower, rebuilds into the event or stays quiet.
See the live data behind this article on ORTEX.
Open BNY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
